RxDoctor Payments Data

Kenneth Dovidio, PA

Physician Assistant · North Andover, MANPI 1891812061

Payments from drug & device makers

$5,958in general payments, 2019–2025

Across 315 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$932
  • Gilead$522
  • Pfizer$493
  • GSK$422
  • Boehringer Ingelheim$359
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,79197%
  • Education$1673%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,958 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$26,193
Medicare patients
89
Services billed
302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab12$65,011
OzempicSemaglutide52$59,778
JardianceEmpagliflozin35$44,646
EliquisApixaban37$31,060
MounjaroTirzepatide18$19,576
FarxigaDapagliflozin Propanediol23$15,503
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,989
XareltoRivaroxaban13$7,182
Breo ElliptaFluticasone/Vilanterol14$5,605
Carvedilol ErCarvedilol Phosphate12$1,850
Atorvastatin Calcium126$1,632
Albuterol Sulfate HfaAlbuterol Sulfate56$1,506
Testosterone Cypionate46$1,349
Omeprazole66$1,234
Metoprolol Succinate70$1,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$241$59,77852 claims
Boehringer IngelheimJardiance$359$44,64635 claims
PfizerEliquis$493$31,06037 claims
Lilly USA, LLCMounjaro$133$19,57618 claims
GSKTrelegy Ellipta, Breo Ellipta$422$16,59431 claims
AstraZenecaFarxiga$932$15,50323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in North Andover

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →